Well that BP note is handy from the point of view of suggesting timelines for 2591
If we had to outline a very broad outline of "company focus by year" for the next couple of years for me it looks like this:
2014 Rett
2015 FXS
2016 concussion/TBI
2017 MS
The TBI stuff could come in 2015, of course, but FXS is arguably the biggest market and the gateway into the broader autism market.
Ann: Neuren advances NNZ-2591 towards IND application, page-28
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |